An interdisciplinary research team received a five-year, $2 million grant from the National Science Foundation to develop a new generation of biosynthetic lubricants that have the potential to treat arthritis and reduce the painful friction of artificial joints.
Weill Cornell Medicine has been awarded a five-year, $11.6 million grant from the National Institute on Drug Abuse of the National Institutes of Health to study the effects cannabis, including marijuana and compounds derived from it, may have on the brains of those living with HIV.
Cornell researchers attached large fragments to temperamental "radical" molecules, increasing their girth to insulate them from their hyperreactive partners – a method that could help create improved derivatives of pharmaceutical compounds.
A member of an important class of ion channel proteins can transiently rearrange itself into a larger structure with dramatically altered properties, according to a study led by researchers at Weill Cornell Medicine.
Our 11th episode features Stephanie Wisner ’16, co-founder of Centivax, a therapeutics company that’s creating universal vaccines to reduce and eradicate the remaining complex pathogens of the 21st century.
The hackathons, run by Entrepreneurship at Cornell, are open to undergraduate and graduate students from any field and major and take place from Friday evenings through Sunday afternoon.
An atlas that catalogues gene activity and the levels of small molecules called metabolites in tumor samples offers a new way of identifying the deep mechanisms of cancer.
An international phase 3 clinical trial found that a new targeted treatment, given in combination with a standard chemotherapy, extended survival for select patients with advanced gastric or gastroesophageal junction cancer.